October 2006 Vol 6 No 9
IN THIS
ISSUE
INTERVIEW WITH
AZOPHARMA’S CEO
MR. PHIL
MEEKS
Combination
Products 24
Christine M. Ford, MBA
Hybrid Business
Model 26
Mr. Anthony Garramone
Ms. Debra Bingham
RTF® Sterile
Syringes
Mr. H. Burkhard
Lingenberg
38
HFA Valve
Technology 61
Guillaume Brouet, MSc
Christophe Jacuk, MS
Erosion Versus
Diffusion 71
Neena Washington, PhD
Professor Clive G. Wilson
The science & business of specialty pharma, biotechnology, and drug delivery
Mr. Dave A.
Miller
Properties of
Chitosan as a
Retardant Binder in
Matrix Tablets for
Sustained Release
Philip L.
Smith, PhD
Formulation
Strategies to
Protect Multi-Billion
Dollar Blockbusters
Miss
Megha
Barot
Novel Particle
Engineering
Technology:
A Review
Preservative Free
Applications 91
René Bommer, PhD
Mr. Jochen Kern
www.drugdeliverytech.com
